Cargando…

Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes

OBJECTIVE: To determine the role of markers of plasma protein damage by glycation, oxidation and nitration in microalbuminuria onset or subsequent decline of glomerular filtration rate (termed “early GFR decline”) in patients with type 1 diabetes. METHODS: From the 1(st) Joslin Kidney Study, we sele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perkins, Bruce A., Rabbani, Naila, Weston, Andrew, Ficociello, Linda H., Adaikalakoteswari, Antonysunil, Niewczas, Monika, Warram, James, Krolewski, Andrzej S., Thornalley, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338454/ https://www.ncbi.nlm.nih.gov/pubmed/22558190 http://dx.doi.org/10.1371/journal.pone.0035655

Ejemplares similares

High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
por: Perkins, Bruce A., et al.
Publicado: (2020)

Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease
por: Rabbani, Naila, et al.
Publicado: (2022)

Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes
por: Ficociello, Linda H., et al.
Publicado: (2009)

Increased DNA Dicarbonyl Glycation and Oxidation Markers in Patients with Type 2 Diabetes and Link to Diabetic Nephropathy
por: Waris, Sahar, et al.
Publicado: (2015)

Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis
por: Anwar, Attia, et al.
Publicado: (2018)

Activation of NF-E2–Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease
por: Xue, Mingzhan, et al.
Publicado: (2008)

Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2012)

Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type-1 diabetes
por: Merchant, Michael L., et al.
Publicado: (2013)

The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
por: Meerwaldt, Robbert, et al.
Publicado: (2008)

Adherence to Mediterranean diet and advanced glycation endproducts in patients with diabetes
por: Grahovac, Marko, et al.
Publicado: (2021)

An Introduction to the Special Issue “Protein Glycation in Food, Nutrition, Health and Disease”
por: Rabbani, Naila, et al.
Publicado: (2022)

Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
por: Rabbani, Naila, et al.
Publicado: (2022)

Transcriptome Analysis of Proximal Tubular Cells (HK-2) Exposed to Urines of Type 1 Diabetes Patients at Risk of Early Progressive Renal Function Decline
por: Wanic, Krzysztof, et al.
Publicado: (2013)

Mass spectrometric determination of early and advanced glycation in biology
por: Rabbani, Naila, et al.
Publicado: (2016)

Dicarbonyl stress, protein glycation and the unfolded protein response
por: Rabbani, Naila, et al.
Publicado: (2021)

Increased Glycation and Oxidative Damage to Apolipoprotein B100 of LDL Cholesterol in Patients With Type 2 Diabetes and Effect of Metformin
por: Rabbani, Naila, et al.
Publicado: (2010)

Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390
por: Niewczas, Monika A., et al.
Publicado: (2017)

Advanced glycation endproducts in the development of osteoarthritis
por: DeGroot, J, et al.
Publicado: (2004)

Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
por: Rabbani, Naila, et al.
Publicado: (2021)

High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes: Results of a 6-year follow-up
por: Ficociello, Linda H., et al.
Publicado: (2010)

Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice
por: Rubin, Mishaela R., et al.
Publicado: (2016)

Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies
por: Wanic, Krzysztof, et al.
Publicado: (2008)

Protein Glycation in Plants—An Under-Researched Field with Much Still to Discover
por: Rabbani, Naila, et al.
Publicado: (2020)

Dietary Advanced Glycation Endproducts and the Gastrointestinal Tract
por: van der Lugt, Timme, et al.
Publicado: (2020)

Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA(1c) in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria
por: Skupien, Jan, et al.
Publicado: (2014)

Imaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes
por: Tekabe, Yared, et al.
Publicado: (2011)

Correction: Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice
por: Rubin, Mishaela R., et al.
Publicado: (2016)

Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy
por: Kanda, Atsuhiro, et al.
Publicado: (2017)

Effects of Advanced Glycation Endproducts on the Mechanical Properties of Posterior Tibialis in Individuals with Diabetes Mellitus
por: Zellers, Jennifer A., et al.
Publicado: (2019)

Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity: A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes
por: Rabbani, Naila, et al.
Publicado: (2011)

Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
por: Krolewski, Andrzej S.
Publicado: (2015)

Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification
por: van Eupen, Marcelle GA, et al.
Publicado: (2013)

Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice
por: McVicar, Carmel M., et al.
Publicado: (2015)

The role of receptor for advanced glycation endproducts (RAGE) in infection
por: van Zoelen , Marieke AD, et al.
Publicado: (2011)

Advanced Glycation Endproducts Interfere with Adhesion and Neurite Outgrowth
por: Bennmann, Dorit, et al.
Publicado: (2014)

Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis
por: Wetzels, Suzan, et al.
Publicado: (2017)

The Role of Receptor for Advanced Glycation Endproducts (RAGE) in Infection
por: van Zoelen, M. A. D., et al.
Publicado: (2011)

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease
por: Skupien, Jan, et al.
Publicado: (2012)

Advanced Glycation End Products in Extracellular Matrix Proteins Contribute to the Failure of Sensory Nerve Regeneration in Diabetes
por: Duran-Jimenez, Beatriz, et al.
Publicado: (2009)

Increased plasma Kidney Injury Molecule-1 suggests early progressive renal decline in non-proteinuric patients with Type 1 diabetes
por: Nowak, Natalia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ajnfprjr5clgk4cmaq75vqahdk